$0.00
(+0.00%
) Quote details
USD
+$0.00
(+0.00%
)At Close (As of Dec 12, 2025)
$3.40B
Market Cap
-
P/E Ratio
-3.89
EPS
$46.60
52 Week High
$26.74
52 Week Low
HEALTHCARE
Sector
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Xenon Pharmaceuticals Inc. (XENE) is a clinical-stage biopharmaceutical company based in Burnaby, Canada, focused on developing innovative therapies for neurological disorders. The company boasts a robust pipeline of drug candidates designed to address genetic and rare conditions, leveraging advanced technologies to improve patient outcomes and enhance treatment options. With a strong commitment to scientific excellence and a patient-centric approach, Xenon positions itself as a key player in the biopharmaceutical landscape, aiming to deliver transformative healthcare solutions on a global scale.
LPTX
NVDA
CGC
WOK
PLUG
ASST
TSLA
AVGO
INTC
TLRY
IQ
TNYA
KAVL
ASBP
ORCL
SOFI
PFE
ADAP
DNN
HPE
NFLX
F
AAL
PLTD
KVUE
WBD
VHAI
WULF
UGRO
MARA
PLTR
RR
BYND
VALE
BAC
APLT
SNAP
CLSK
BITF
IVP
AMD
GOOGL
IREN
IRBT
T
CVE
RIG
RKLB
QBTS
NIO
HOOD
CIFR
RGTI
GRAB
CAN
SMR
CMG
MTSR
SOUN
MU
JBLU
HL
KIND
IBRX
NOK
AG
APLD
BTBT
CDE
LPTX
NVDA
CGC
WOK
PLUG
ASST
TSLA
AVGO
INTC
TLRY
IQ
TNYA
KAVL
ASBP
ORCL
SOFI
PFE
ADAP
DNN
HPE
NFLX
F
AAL
PLTD
KVUE
WBD
VHAI
WULF
UGRO
MARA
PLTR
RR
BYND
VALE
BAC
APLT
SNAP
CLSK
BITF
IVP
AMD
GOOGL
IREN
IRBT
T
CVE
RIG
RKLB
QBTS
NIO
HOOD
CIFR
RGTI
GRAB
CAN
SMR
CMG
MTSR
SOUN
MU
JBLU
HL
KIND
IBRX
NOK
AG
APLD
BTBT
CDE